GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » HLB Life Science Co Ltd (XKRX:067630) » Definitions » EV-to-EBITDA

HLB Life Science Co (XKRX:067630) EV-to-EBITDA : -4.44 (As of May. 29, 2025)


View and export this data going back to 2008. Start your Free Trial

What is HLB Life Science Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, HLB Life Science Co's enterprise value is ₩801,752 Mil. HLB Life Science Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-180,488 Mil. Therefore, HLB Life Science Co's EV-to-EBITDA for today is -4.44.

The historical rank and industry rank for HLB Life Science Co's EV-to-EBITDA or its related term are showing as below:

XKRX:067630' s EV-to-EBITDA Range Over the Past 10 Years
Min: -2232.61   Med: -11.65   Max: 931.24
Current: -4.44

During the past 13 years, the highest EV-to-EBITDA of HLB Life Science Co was 931.24. The lowest was -2232.61. And the median was -11.65.

XKRX:067630's EV-to-EBITDA is ranked worse than
100% of 97 companies
in the Medical Distribution industry
Industry Median: 9.18 vs XKRX:067630: -4.44

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-29), HLB Life Science Co's stock price is ₩6180.00. HLB Life Science Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-1766.000. Therefore, HLB Life Science Co's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


HLB Life Science Co EV-to-EBITDA Historical Data

The historical data trend for HLB Life Science Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Life Science Co EV-to-EBITDA Chart

HLB Life Science Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.76 -21.13 -22.78 54.88 47.62

HLB Life Science Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.20 46.64 13.21 47.62 -4.59

Competitive Comparison of HLB Life Science Co's EV-to-EBITDA

For the Medical Distribution subindustry, HLB Life Science Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Life Science Co's EV-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, HLB Life Science Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where HLB Life Science Co's EV-to-EBITDA falls into.


;
;

HLB Life Science Co EV-to-EBITDA Calculation

HLB Life Science Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=801751.859/-180488.07
=-4.44

HLB Life Science Co's current Enterprise Value is ₩801,752 Mil.
HLB Life Science Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-180,488 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLB Life Science Co  (XKRX:067630) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

HLB Life Science Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6180.00/-1766.000
=At Loss

HLB Life Science Co's share price for today is ₩6180.00.
HLB Life Science Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1766.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


HLB Life Science Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of HLB Life Science Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Life Science Co Business Description

Traded in Other Exchanges
N/A
Address
3-10th Floor, Pangyo Seven Venture Valley 1-danji, 15, Pangyo-ro 228 beon-gil, Gyeonggi-do, Seongnam-si, KOR
HLB Life Science Co Ltd is engaged in the energy services and renewable energy businesses. It offers energy-saving facilities, condensing water recovery systems, cogeneration systems, and solar energy development systems. In addition to the existing energy business, the firm is also engaged in investing in new drug development and medical-related field.

HLB Life Science Co Headlines

No Headlines